Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
about
Glucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesityNew perspectives on exploitation of incretin peptides for the treatment of diabetes and related disordersBrain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
P2860
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Synergistic metabolic benefits ...... and leptin-deficient rodents.
@en
type
label
Synergistic metabolic benefits ...... and leptin-deficient rodents.
@en
prefLabel
Synergistic metabolic benefits ...... and leptin-deficient rodents.
@en
P2093
P2860
P356
P1476
Synergistic metabolic benefits ...... and leptin-deficient rodents.
@en
P2093
D G Parkes
J Athanacio
K Tatarkiewicz
P2860
P356
10.1111/DOM.12390
P577
2014-10-14T00:00:00Z